Integrative characterisation of Novel adenovirus VECtors aimed at Therapeutic Applications

Project Information

INVECTA

Grant agreement ID: 101129778

DOI 10.3030/101129778

EC signature date 22 September 2023

Start date 1 December 2023

End date 30 November 2027

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost € 0,00

EU contribution € 197 800,00

Coordinated by

RUDER BOSKOVIC INSTITUTE
Croatia

Deliverables

Other (1)

Management structure

Document describing roles and position within the management structure of the INVECTA